142 related articles for article (PubMed ID: 20206668)
1. Codon-optimization of the hemagglutinin gene from the novel swine origin H1N1 influenza virus has differential effects on CD4(+) T-cell responses and immune effector mechanisms following DNA electroporation in mice.
Tenbusch M; Grunwald T; Niezold T; Storcksdieck Genannt Bonsmann M; Hannaman D; Norley S; Uberla K
Vaccine; 2010 Apr; 28(19):3273-7. PubMed ID: 20206668
[TBL] [Abstract][Full Text] [Related]
2. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
[TBL] [Abstract][Full Text] [Related]
3. Immunization with a low dose of hemagglutinin-encoding plasmid protects against 2009 H1N1 pandemic influenza virus in mice.
Fang J; Chen Z; Liu X; Li H; Wang J; Shen X; Chen W; Liu Y; Wang Y; Zhao P; Qi Z
J Virol Methods; 2011 May; 173(2):314-9. PubMed ID: 21392537
[TBL] [Abstract][Full Text] [Related]
4. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
[TBL] [Abstract][Full Text] [Related]
5. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of seasonal pandemic influenza hemagglutinin DNA vaccines delivered by electroporation against a seasonal H1N1 virus challenge in mice.
Tan L; Lu H; Zhang D; Wang K; Tian M; Liu C; Liu Y; Hu B; Jin N
Sci China Life Sci; 2011 Apr; 54(4):293-9. PubMed ID: 21416231
[TBL] [Abstract][Full Text] [Related]
7. Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein.
James CM; Abdad MY; Mansfield JP; Jacobsen HK; Vind AR; Stumbles PA; Bartlett EJ
Vaccine; 2007 Feb; 25(10):1856-67. PubMed ID: 17240000
[TBL] [Abstract][Full Text] [Related]
8. Construction and cellular immune response induction of HA-based alphavirus replicon vaccines against human-avian influenza (H5N1).
Yang SG; Wo JE; Li MW; Mi FF; Yu CB; Lv GL; Cao HC; Lu HF; Wang BH; Zhu H; Li LJ
Vaccine; 2009 Dec; 27(52):7451-8. PubMed ID: 19450640
[TBL] [Abstract][Full Text] [Related]
9. Sindbis virus vectors elicit hemagglutinin-specific humoral and cellular immune responses and offer a dose-sparing strategy for vaccination.
Miller A; Center RJ; Stambas J; Deliyannis G; Doherty PC; Howard JL; Turner SJ; Purcell DF
Vaccine; 2008 Oct; 26(44):5641-8. PubMed ID: 18761047
[TBL] [Abstract][Full Text] [Related]
10. Characterization of antibodies specific for hemagglutinin and neuraminidase proteins of the 1918 and 2009 pandemic H1N1 viruses.
Liu Y; Liu X; Fang J; Shen X; Chen W; Lin X; Li H; Tan W; Wang Y; Zhao P; Qi Z
Vaccine; 2010 Dec; 29(2):183-90. PubMed ID: 21055499
[TBL] [Abstract][Full Text] [Related]
11. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
[TBL] [Abstract][Full Text] [Related]
12. Plasmid DNA vaccines are effective in the absence of IFNgamma.
Hassett DE; Zhang J; Whitton JL
Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
[TBL] [Abstract][Full Text] [Related]
13. Mutant influenza A virus nucleoprotein is preferentially localized in the cytoplasm and its immunization in mice shows higher immunogenicity and cross-reactivity.
Ohba K; Yoshida S; Zahidunnabi Dewan M; Shimura H; Sakamaki N; Takeshita F; Yamamoto N; Okuda K
Vaccine; 2007 May; 25(21):4291-300. PubMed ID: 17403560
[TBL] [Abstract][Full Text] [Related]
14. Novel synthetic plasmid and Doggybone DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice.
Scott VL; Patel A; Villarreal DO; Hensley SE; Ragwan E; Yan J; Sardesai NY; Rothwell PJ; Extance JP; Caproni LJ; Weiner DB
Hum Vaccin Immunother; 2015; 11(8):1972-82. PubMed ID: 26091432
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the vaccine potential of an influenza A viral hemagglutinin and matrix double insertion DNA plasmid.
Xie H; Liu T; Chen H; Huang X; Ye Z
Vaccine; 2007 Nov; 25(44):7649-55. PubMed ID: 17913307
[TBL] [Abstract][Full Text] [Related]
16. Cellular immune response in the presence of protective antibody levels correlates with protection against 1918 influenza in ferrets.
Pillet S; Kobasa D; Meunier I; Gray M; Laddy D; Weiner DB; von Messling V; Kobinger GP
Vaccine; 2011 Sep; 29(39):6793-801. PubMed ID: 21211587
[TBL] [Abstract][Full Text] [Related]
17. Fusion of C3d with hemagglutinin enhances protective immunity against swine influenza virus.
Li GX; Tian ZJ; Yu H; Jin YY; Hou SH; Zhou YJ; Liu TQ; Hu SP; Tong GZ
Res Vet Sci; 2009 Jun; 86(3):406-13. PubMed ID: 19010505
[TBL] [Abstract][Full Text] [Related]
18. Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccination.
Subbramanian RA; Basha S; Shata MT; Brady RC; Bernstein DI
Vaccine; 2010 Dec; 28(52):8258-67. PubMed ID: 21050903
[TBL] [Abstract][Full Text] [Related]
19. Inverted terminal repeat sequences of adeno-associated virus enhance the antibody and CD8(+) responses to a HIV-1 p55Gag/LAMP DNA vaccine chimera.
Chikhlikar P; Barros de Arruda L; Agrawal S; Byrne B; Guggino W; August JT; Marques ET
Virology; 2004 Jun; 323(2):220-32. PubMed ID: 15193918
[TBL] [Abstract][Full Text] [Related]
20. Identification of effective constituents of influenza vaccine by immunization with plasmid DNAs encoding viral proteins.
Ze C; Kurata T; Tamura S
Jpn J Infect Dis; 2000 Dec; 53(6):219-28. PubMed ID: 11227019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
